Cargando…
Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells
Triple Negative Breast Cancer (TNBC) is the aggressive and lethal type of breast malignancy that develops resistance to current therapies. Combination therapy has proven to be an effective strategy on TNBC. We aimed to study whether the nano-formulation of polyphenolic curcumin (Gemini-Cur) would af...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104165/ https://www.ncbi.nlm.nih.gov/pubmed/35566271 http://dx.doi.org/10.3390/molecules27092917 |
_version_ | 1784707727935668224 |
---|---|
author | Karami, Parastoo Othman, Goran Housein, Zjwan Salihi, Abbas Hosseinpour Feizi, Mohammad Ali Azeez, Hewa Jalal Babaei, Esmaeil |
author_facet | Karami, Parastoo Othman, Goran Housein, Zjwan Salihi, Abbas Hosseinpour Feizi, Mohammad Ali Azeez, Hewa Jalal Babaei, Esmaeil |
author_sort | Karami, Parastoo |
collection | PubMed |
description | Triple Negative Breast Cancer (TNBC) is the aggressive and lethal type of breast malignancy that develops resistance to current therapies. Combination therapy has proven to be an effective strategy on TNBC. We aimed to study whether the nano-formulation of polyphenolic curcumin (Gemini-Cur) would affect the cisplatin-induced toxicity in MDA-MB-231 breast cancer cells. MDA-MB-231 cells were treated with Gemini-Cur, cisplatin and combination of Gemini-Cur/Cisplatin in a time- and dose-dependent manner. Cell viability was studied by using MTT, fluorescence microscopy and cell cycle assays. The mode of death was also determined by Hoechst staining and annexin V-FITC. Real-time PCR and western blotting were employed to detect the expression of BAX and BCL-2 genes. Our data demonstrated that Gemini-Cur significantly sensitizes cancer cells to cisplatin (combination index ≤ 1) and decreases IC50 values in comparison with Gemini-cur or cisplatin. Further studies confirmed that Gemini-Cur/Cisplatin suppresses cancer cell growth through induction of apoptosis (p < 0.001). In conclusion, the data confirm the synergistic effect of polyphenolic curcumin on cisplatin toxicity and provide attractive strategy to attain its apoptotic effect on TNBC. |
format | Online Article Text |
id | pubmed-9104165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91041652022-05-14 Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells Karami, Parastoo Othman, Goran Housein, Zjwan Salihi, Abbas Hosseinpour Feizi, Mohammad Ali Azeez, Hewa Jalal Babaei, Esmaeil Molecules Article Triple Negative Breast Cancer (TNBC) is the aggressive and lethal type of breast malignancy that develops resistance to current therapies. Combination therapy has proven to be an effective strategy on TNBC. We aimed to study whether the nano-formulation of polyphenolic curcumin (Gemini-Cur) would affect the cisplatin-induced toxicity in MDA-MB-231 breast cancer cells. MDA-MB-231 cells were treated with Gemini-Cur, cisplatin and combination of Gemini-Cur/Cisplatin in a time- and dose-dependent manner. Cell viability was studied by using MTT, fluorescence microscopy and cell cycle assays. The mode of death was also determined by Hoechst staining and annexin V-FITC. Real-time PCR and western blotting were employed to detect the expression of BAX and BCL-2 genes. Our data demonstrated that Gemini-Cur significantly sensitizes cancer cells to cisplatin (combination index ≤ 1) and decreases IC50 values in comparison with Gemini-cur or cisplatin. Further studies confirmed that Gemini-Cur/Cisplatin suppresses cancer cell growth through induction of apoptosis (p < 0.001). In conclusion, the data confirm the synergistic effect of polyphenolic curcumin on cisplatin toxicity and provide attractive strategy to attain its apoptotic effect on TNBC. MDPI 2022-05-03 /pmc/articles/PMC9104165/ /pubmed/35566271 http://dx.doi.org/10.3390/molecules27092917 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karami, Parastoo Othman, Goran Housein, Zjwan Salihi, Abbas Hosseinpour Feizi, Mohammad Ali Azeez, Hewa Jalal Babaei, Esmaeil Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title | Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title_full | Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title_fullStr | Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title_full_unstemmed | Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title_short | Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells |
title_sort | nanoformulation of polyphenol curcumin enhances cisplatin-induced apoptosis in drug-resistant mda-mb-231 breast cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104165/ https://www.ncbi.nlm.nih.gov/pubmed/35566271 http://dx.doi.org/10.3390/molecules27092917 |
work_keys_str_mv | AT karamiparastoo nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT othmangoran nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT houseinzjwan nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT salihiabbas nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT hosseinpourfeizimohammadali nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT azeezhewajalal nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells AT babaeiesmaeil nanoformulationofpolyphenolcurcuminenhancescisplatininducedapoptosisindrugresistantmdamb231breastcancercells |